Prostate cancer: Rescreening policies and risk calculators (Q88186580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

title

Prostate cancer: Rescreening policies and risk calculators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

429-430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

Risk stratification in prostate cancer screening.

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

Prostate-cancer mortality at 11 years of follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

A graphical device to represent the outcomes of a logistic regression analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

Balancing the harms and benefits of early detection of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2014.142

31 March 2020

Identifiers

DOI

10.1038/NRUROL.2014.142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24980199 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference